Global Liquid Biopsy Diagnostic Tool Market Research Report 2023

Publication ID:

PB501231348

Publication Date:

January 16, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Highlights
The global Liquid Biopsy Diagnostic Tool market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Liquid Biopsy Diagnostic Tool is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Liquid Biopsy Diagnostic Tool is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Liquid Biopsy Diagnostic Tool in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Liquid Biopsy Diagnostic Tool include Biocept, Qiagen, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini-Silicon Biosystems, Trovagene, Guardant Health and Mdxhealth, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liquid Biopsy Diagnostic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Biopsy Diagnostic Tool.
The Liquid Biopsy Diagnostic Tool market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Liquid Biopsy Diagnostic Tool market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Biopsy Diagnostic Tool companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Biocept
Qiagen
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina
Amoy Diagnostics
Johnson & Johnson
Segment by Type
Instrument
Reagent
Other
Segment by Application
Hospital
Third-party Testing Agency
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Biopsy Diagnostic Tool companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Instrument
1.2.3 Reagent
1.2.4 Other
1.3 Market by Application
1.3.1 Global Liquid Biopsy Diagnostic Tool Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Third-party Testing Agency
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liquid Biopsy Diagnostic Tool Market Perspective (2018-2029)
2.2 Liquid Biopsy Diagnostic Tool Growth Trends by Region
2.2.1 Global Liquid Biopsy Diagnostic Tool Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Liquid Biopsy Diagnostic Tool Historic Market Size by Region (2018-2023)
2.2.3 Liquid Biopsy Diagnostic Tool Forecasted Market Size by Region (2024-2029)
2.3 Liquid Biopsy Diagnostic Tool Market Dynamics
2.3.1 Liquid Biopsy Diagnostic Tool Industry Trends
2.3.2 Liquid Biopsy Diagnostic Tool Market Drivers
2.3.3 Liquid Biopsy Diagnostic Tool Market Challenges
2.3.4 Liquid Biopsy Diagnostic Tool Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liquid Biopsy Diagnostic Tool Players by Revenue
3.1.1 Global Top Liquid Biopsy Diagnostic Tool Players by Revenue (2018-2023)
3.1.2 Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Players (2018-2023)
3.2 Global Liquid Biopsy Diagnostic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid Biopsy Diagnostic Tool Revenue
3.4 Global Liquid Biopsy Diagnostic Tool Market Concentration Ratio
3.4.1 Global Liquid Biopsy Diagnostic Tool Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Biopsy Diagnostic Tool Revenue in 2022
3.5 Liquid Biopsy Diagnostic Tool Key Players Head office and Area Served
3.6 Key Players Liquid Biopsy Diagnostic Tool Product Solution and Service
3.7 Date of Enter into Liquid Biopsy Diagnostic Tool Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liquid Biopsy Diagnostic Tool Breakdown Data by Type
4.1 Global Liquid Biopsy Diagnostic Tool Historic Market Size by Type (2018-2023)
4.2 Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Type (2024-2029)
5 Liquid Biopsy Diagnostic Tool Breakdown Data by Application
5.1 Global Liquid Biopsy Diagnostic Tool Historic Market Size by Application (2018-2023)
5.2 Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Liquid Biopsy Diagnostic Tool Market Size (2018-2029)
6.2 North America Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Liquid Biopsy Diagnostic Tool Market Size by Country (2018-2023)
6.4 North America Liquid Biopsy Diagnostic Tool Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liquid Biopsy Diagnostic Tool Market Size (2018-2029)
7.2 Europe Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2018-2023)
7.4 Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size (2018-2029)
8.2 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Region (2018-2023)
8.4 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liquid Biopsy Diagnostic Tool Market Size (2018-2029)
9.2 Latin America Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2018-2023)
9.4 Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size (2018-2029)
10.2 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2018-2023)
10.4 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Detail
11.1.2 Biocept Business Overview
11.1.3 Biocept Liquid Biopsy Diagnostic Tool Introduction
11.1.4 Biocept Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.1.5 Biocept Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Detail
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Liquid Biopsy Diagnostic Tool Introduction
11.2.4 Qiagen Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.2.5 Qiagen Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Liquid Biopsy Diagnostic Tool Introduction
11.3.4 Roche Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.3.5 Roche Diagnostics Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Introduction
11.4.4 Bio-Rad Laboratories Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Detail
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Liquid Biopsy Diagnostic Tool Introduction
11.5.4 Myriad Genetics Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.5.5 Myriad Genetics Recent Development
11.6 Menarini-Silicon Biosystems
11.6.1 Menarini-Silicon Biosystems Company Detail
11.6.2 Menarini-Silicon Biosystems Business Overview
11.6.3 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Introduction
11.6.4 Menarini-Silicon Biosystems Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.6.5 Menarini-Silicon Biosystems Recent Development
11.7 Trovagene
11.7.1 Trovagene Company Detail
11.7.2 Trovagene Business Overview
11.7.3 Trovagene Liquid Biopsy Diagnostic Tool Introduction
11.7.4 Trovagene Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.7.5 Trovagene Recent Development
11.8 Guardant Health
11.8.1 Guardant Health Company Detail
11.8.2 Guardant Health Business Overview
11.8.3 Guardant Health Liquid Biopsy Diagnostic Tool Introduction
11.8.4 Guardant Health Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.8.5 Guardant Health Recent Development
11.9 Mdxhealth
11.9.1 Mdxhealth Company Detail
11.9.2 Mdxhealth Business Overview
11.9.3 Mdxhealth Liquid Biopsy Diagnostic Tool Introduction
11.9.4 Mdxhealth Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.9.5 Mdxhealth Recent Development
11.10 Genomic Health
11.10.1 Genomic Health Company Detail
11.10.2 Genomic Health Business Overview
11.10.3 Genomic Health Liquid Biopsy Diagnostic Tool Introduction
11.10.4 Genomic Health Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.10.5 Genomic Health Recent Development
11.11 Raindance Technologies
11.11.1 Raindance Technologies Company Detail
11.11.2 Raindance Technologies Business Overview
11.11.3 Raindance Technologies Liquid Biopsy Diagnostic Tool Introduction
11.11.4 Raindance Technologies Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.11.5 Raindance Technologies Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Introduction
11.12.4 Thermo Fisher Scientific Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Illumina
11.13.1 Illumina Company Detail
11.13.2 Illumina Business Overview
11.13.3 Illumina Liquid Biopsy Diagnostic Tool Introduction
11.13.4 Illumina Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.13.5 Illumina Recent Development
11.14 Amoy Diagnostics
11.14.1 Amoy Diagnostics Company Detail
11.14.2 Amoy Diagnostics Business Overview
11.14.3 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Introduction
11.14.4 Amoy Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.14.5 Amoy Diagnostics Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Detail
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Liquid Biopsy Diagnostic Tool Introduction
11.15.4 Johnson & Johnson Revenue in Liquid Biopsy Diagnostic Tool Business (2018-2023)
11.15.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Biocept
Qiagen
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina
Amoy Diagnostics
Johnson & Johnson

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂